Department of Obstetrics and Gynaecology

Erratum: Author Correction: Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus (Nature communications (2016) 7DOI: 10.1038/ncomms12675.) (2025) Lawrenson K, Kar S, McCue K, Kuchenbaeker K, Michailidou K, Tyrer J, Beesley J, et al. Journal article, Erratum The Epidemiology of Cervical Cancer in Germany: A Registry-Based Analysis of Incidence, Survival, and Tumor Characteristics (2003–2021) (2025) Stübs F, Beckmann M, Pöschke P, Heindl F, Emons J, Gaß P, Häberle L Journal article Reply to: Germline and Somatic BRCA1/2 Mutations in Breast Cancer Treatment Strategies (2025) Hahnen E, Hauke J, Gelmon K, Marmé F, Ernst C, Martin M, Untch M, et al. Journal article, Letter The SURVIVE study (NCT05658172): Bringing breast cancer aftercare to the 21stcentury: Study protocol of a Phase III clinical trial comparing liquid biopsy guided vs. Standard of care surveillance for intermediate to high-risk breast cancer survivors (2025) Braun T, Huesmann S, Pfister K, Friedl TW, Hartkopf A, Pantel K, Mehmeti F, et al. Journal article Risk for non-sentinel metastases in the contralateral groin in patients with a unilateral positive sentinel lymph node in primary vulvar cancer- a subgroup analysis of the AGO-VOP.2 QS Vulva Study (2025) Jaeger A, Hampl M, Prieske K, Eulenburg C, Reichenbach J, Klapdor R, Heublein S, et al. Journal article ASO Author Reflections: ‘Right-sizing’ the Treatment Approach for Small HER2 Positive Breast Cancers (2025) Müller C, Rangan R, Kruse M, Al-Hilli Z Journal article Robust Consensus Molecular Subtyping of Muscle-Invasive Bladder Cancer Via 3' RNA Sequencing of Formalin-Fixed Paraffin-Embedded Tissues: Potential Impact for Clinical and Trial Settings (2025) Angeloni M, Wach S, Taubert H, Sikic D, Wullich B, Matek C, Strick R, et al. Journal article Limited association between HRR gene alterations and HRD in molecular tumor board cancer samples: Who should be tested for HRD? (2025) Schubart C, Tögel L, Carta MG, Hetzner P, Helbig L, Zaglas C, Ziegler M, et al. Journal article Adherence to digital pregnancy care – lessons learned from the SMART start feasibility study (2025) Jäger K, Nissen M, Leutheuser H, Danzberger N, Titzmann A, Pontones C, Goossens C, et al. Journal article First-Line Camizestrant for Emerging ESR1 -Mutated Advanced Breast Cancer. (2025) Bidard FC, Mayer EL, Park YH, Janni W, Ma C, Cristofanilli M, Bianchini G, et al. Journal article